Related Experiment Video
Updated: Aug 15, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
[Stem cell therapy for chronic cardiac insufficiency--therapy of the future?]
W M Franz1, H D Theiss, G Steinbeck
1Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Grosshadern. wolfgang.franz@med.uni-muenchen.de
Insights
Chronic cardiac insufficiency is rising, with limited treatments. Embryonic stem cells offer a promising future therapy, potentially regenerating heart muscle tissue through tissue engineering for transplantation.
Area of Science:
- Cardiology
- Regenerative Medicine
- Biotechnology
Background:
- The increasing incidence of chronic cardiac insufficiency presents a significant clinical challenge.
- Current therapeutic options for end-stage heart failure are limited by donor organ scarcity.
- Stem cell therapy is emerging as a potential future treatment strategy.
Purpose of the Study:
- To explore the potential of embryonic stem cells (ESCs) in treating chronic cardiac insufficiency.
- To investigate the feasibility of using tissue engineering with ESCs to generate functional myocardium.
- To address the limitations of current therapies for end-stage heart failure.
Main Methods:
- Utilizing the pluripotent nature of embryonic stem cells for potential cardiac tissue regeneration.
- Employing tissue engineering techniques to develop transplantable myocardial tissue.
- Evaluating the theoretical capacity of ESCs for indefinite proliferation in cell culture.
Main Results:
- Embryonic stem cells are pluripotent and capable of indefinite division in vitro.
- Tissue engineering holds the potential to generate new myocardium from ESCs.
- This approach could theoretically support pump function in patients with chronic cardiac insufficiency.
Conclusions:
- Embryonic stem cells represent a significant therapeutic option for chronic cardiac insufficiency.
- Tissue engineering with ESCs offers a potential solution to the donor organ shortage.
- Further research is needed to verify the clinical efficacy of ESC-based therapies for chronic heart failure.
Abstract:
The incidence of chronic cardiac insufficiency is constantly increasing. However, the current therapeutic possibilities during the terminal stage are limited by a lack of donor organs. For this reason, stem cell therapy is seen as a potent therapeutic option for the future. Catheter application or cytokine-mediated mobilization of autologous adult stem cells is for acute myocardial infarction safe and potentially effective; however, for chronic cardiac insufficiency, the successes have not yet been verifiable. Hence, embryonic stem cells offer a therapeutic option that cannot be ignored: These cells are pluripotent and are, theoretically, able to continue dividing in cell culture indefinitely. Through "tissue engineering" they could generate new myocardium that could be transplanted into patients suffering from chronic cardiac insufficiency to support the pump function.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Cardiomyopathy V: Interprofessional Care
iPS Cell Differentiation

